• Beta-2 Microglobulin, Urine
  • Atypical Pneumonia DNA Panel, Bronchial Wash/Lavage
  • Brucella Culture
  • Ammonia, Serum
  • Pregnenolone
  • TGFB3 Gene Mutation Analysis
  • Trypanosoma cruzi (T. cruzi) Antibody, IgM
  • Gliadin (Deamidated) Antibody, IgG
  • Apolipoprotein Assessment
  • Barrett's-Associated Neoplasia, Cytology
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Diseases (5)
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.